Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5952 USD | -3.67% | -8.37% | +9.55% |
09/05 | Transcript : Sangamo Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
09/05 | Earnings Flash (SGMO) SANGAMO THERAPEUTICS Reports Q1 Revenue $481,000 | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
12Cr | - | |||||
12TCr | ||||||
11TCr | ||||||
2.34TCr | - | |||||
2.18TCr | - | |||||
1.81TCr |